glucose, (beta-d)-isomer has been researched along with Marchiafava-Micheli Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AOKI, K; HORIUCHI, H; ITOO, T; MAEKAWA, T; NAKAO, K; TSUCHIYA, J; YAMATO, K | 1 |
| Baker, PJ; Osofsky, SG; Parker, CJ | 1 |
| Deng, C; Funk, CD; Lambris, JD; Sahu, A; Song, WC; Sun, X | 1 |
| Yachnin, S | 1 |
4 other study(ies) available for glucose, (beta-d)-isomer and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
[A case report of paroxysmal nocturnal hemoglobinuria].
Topics: Hemoglobinuria; Hemoglobinuria, Paroxysmal; Humans; Iron Isotopes; Properdin; Thrombin; Zymosan | 1962 |
Characterization of alternative pathway inhibition by a serum derived, low molecular weight complement inhibitor.
Topics: Cells, Cultured; Complement Activation; Complement C3b; Complement Factor B; Complement Factor D; Complement Inactivator Proteins; Complement Pathway, Alternative; Elapid Venoms; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Magnesium; Zymosan | 1984 |
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.
Topics: Animals; CD55 Antigens; Complement Activation; Complement C3; Erythrocytes; Flow Cytometry; Gene Targeting; Glycosylphosphatidylinositols; Hemoglobinuria, Paroxysmal; Hemolysis; Mice; Mice, Knockout; RNA, Messenger; Zymosan | 1999 |
Role of properdin, O degree factor, polyinosinic acid, and thrombin in the haemolysis of paroxysmal nocturnal haemoglobinuria erythrocytes.
Topics: Cold Temperature; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Polynucleotides; Properdin; Thrombin; Zymosan | 1965 |